Is This Biotech Really Funded by the People, Not Wall Street?

Final Countdown: Cytonics’ Reg A+ Raise Closes August 27th. 

Most biotech cap tables are stacked with venture capital, private equity, and institutional muscle. You know the drill:

• VCs get board seats
• Retail investors get crumbs
• And everyone else finds out about the deal after the IPO

Cytonics Flipped The Script

They’ve raised over $25 million with exactly zero help from Wall Street, venture capital, or private equity firms.

Instead, more than 7,000 everyday investors have joined this grassroots biotech movement, and now, we’re in the final stretch. On August 27th at 11:59 pm, the current Reg A+ round closes forever.

This is your last chance to invest at $3.00 per share, before future raises potentially occur at higher valuations and on very different terms.


Why So Many Investors Have Already Joined

Because this isn’t just a drug company. It’s a rebellion.

Cytonics:

• Completed Phase 1 human trials with zero drug-related adverse events
• Developed CYT-108, a clinical-stage biologic therapy for osteoarthritis
• Secured 25 international patents
• Treated over 10,000 patients with their first-gen therapy
• Did all of this without a single dollar of VC funding

This raise wasn’t designed for fund managers in glass towers.

It was built for you, the believer, the builder, the individual who actually wants a shot at generational upside.


⏳ 14 Days Left. Here’s What That Means for You:

Final Chance: After August 27, you can’t invest in this round. Locked-In Price: Still available at $3.00/share only until the close. No VC Strings: No liquidation preferences, no special share classes. Built by the People: 7,000+ investors already own a piece of the future.

This isn’t just a milestone, it’s a fork in the road.


Ready to Move?

• Invest today; our raise closes August 27th at 11:59 pm
• Only 14 days left to invest at $3.00/share
• Join over 7,000 investors before the window closes
• Secure your stake in the next generation of osteoarthritis treatment

Invest today - Cytonics raise closes August 27th at 11:59 p.m